The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for East Bridge Capital Master Fund I Ltd

Fii Holding DeclinedOwnership Changes View source PDF Explain this filing

JUBLPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.4%Reaction day

₹1158.00

prior close

₹1164.10

announcement price

In-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.5%-1.0% vs market

Pharmaceuticals peers, median of 150sector-0.1%-0.3% vs sector

On the reaction day the stock moved 1.0 pts less than Nifty Smallcap 250 and 0.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

-0.0

30m

+0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.4+0.5-1.0-0.1-0.3

Next day

-1.4+1.2-2.6-0.0-1.4

-2.2+1.9-4.0+0.0-2.2

-1.4+3.2-4.6+0.4-1.8

-0.9+3.4-4.3+1.3-2.2

-1.1+3.3-4.4+1.8-2.9

-5.7+1.4-7.1+1.3-7.0

15d

+2.6+2.9-0.2-1.2+3.8

+3.5+4.7-1.2+1.2+2.2

-0.9+0.3-1.3+0.0-0.9

-8.5-0.6-7.8-2.5-5.9

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 150Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Foreign investor East Bridge Capital Master Fund I Ltd sold 128,235 shares (0.08%) of Jubilant Pharmova on 30 May 2025 through a market transaction. Its holding in the company declined from 3.51% (55,96,522 shares) to 3.43% (54,68,287 shares). The acquirer confirmed it does not belong to the promoter or promoter group. No encumbrance, warrants or convertible instruments were involved in the transaction. The filing is a routine SEBI disclosure triggered because the shareholding change crossed the reporting threshold.

Likely market impact

This is a small, routine open-market sale by a foreign institutional investor, reducing its stake marginally by 0.08%. It is unlikely to have any meaningful impact on the stock price or long-term investor sentiment, as the fund remains a sizeable shareholder with over 3% holding.